Top Institutions in Ophthalmology - Retinal Diseases
Institutions leading in this area are recognized for their pioneering clinical trials in retinal diseases, development of multispecific antibodies, and translational research in ocular inflammation and vascular permeability.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a world leader in retinal disease research and clinical trials, with extensive experience in novel biologic therapies for DME and related retinal vascular diseases.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with a strong focus on diabetic retinopathy and macular edema, leading numerous clinical trials on novel anti-inflammatory and anti-angiogenic agents.
-
#3
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a strong research program in ocular immunology and retinal vascular diseases, contributing to early-phase clinical trials of novel biologics targeting multiple inflammatory pathways in DME.
-
#4
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its comprehensive retinal disease research and clinical trials infrastructure, including studies on novel agents targeting VEGF and inflammatory mediators in DME.
-
#5
University of Illinois at Chicago (UIC) College of Medicine
Chicago, IL
UIC is emerging as a significant contributor in early-phase clinical trials for novel multispecific antibodies in DME, with faculty actively presenting new data on IL-6R targeted therapies.